HONG KONG, May 27, 2018 /PRNewswire/ — Luye Pharma Group recently announced their acquisition of AstraZeneca’s core CNS products – Seroquel and Seroquel XR. As with previous acquisitions such as Lipusu, Xuezhikang, Beixi and Rivastigmine Transdermal Patch, the decision to acquire…
